262.51
price up icon0.74%   1.92
after-market Handel nachbörslich: 262.51
loading
Schlusskurs vom Vortag:
$260.59
Offen:
$260.75
24-Stunden-Volumen:
689.09K
Relative Volume:
0.90
Marktkapitalisierung:
$21.71B
Einnahmen:
$12.71B
Nettoeinkommen (Verlust:
$435.50M
KGV:
50.97
EPS:
5.15
Netto-Cashflow:
$843.20M
1W Leistung:
+0.56%
1M Leistung:
+5.44%
6M Leistung:
+14.71%
1J Leistung:
+28.99%
1-Tages-Spanne:
Value
$259.85
$262.98
1-Wochen-Bereich:
Value
$254.84
$263.50
52-Wochen-Spanne:
Value
$198.96
$264.03

Labcorp Holdings Inc Stock (LH) Company Profile

Name
Firmenname
Labcorp Holdings Inc
Name
Telefon
(336) 229-1127
Name
Adresse
358 S MAIN ST, BURLINGTON, NC
Name
Mitarbeiter
70,000
Name
Twitter
@labcorp
Name
Nächster Verdiensttermin
2024-10-24
Name
Neueste SEC-Einreichungen
Name
LH's Discussions on Twitter

Vergleichen Sie LH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
LH
Labcorp Holdings Inc
262.51 21.71B 12.71B 435.50M 843.20M 5.15
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
405.46 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.54 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
536.34 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
118.01 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
157.59 27.64B 15.50B 1.33B 2.16B 7.34

Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-02 Eingeleitet Redburn Atlantic Buy
2025-03-04 Hochstufung Citigroup Neutral → Buy
2025-01-07 Hochstufung Evercore ISI In-line → Outperform
2024-12-10 Fortgesetzt Jefferies Buy
2024-10-30 Hochstufung HSBC Securities Hold → Buy
2024-10-01 Eingeleitet Piper Sandler Neutral
2024-03-25 Hochstufung Argus Hold → Buy
2024-02-26 Eingeleitet Leerink Partners Outperform
2024-02-09 Eingeleitet Evercore ISI In-line
2024-01-03 Eingeleitet Barclays Equal Weight
2023-09-06 Eingeleitet HSBC Securities Hold
2022-12-12 Herabstufung Citigroup Buy → Neutral
2022-09-19 Herabstufung Argus Buy → Hold
2022-08-22 Fortgesetzt Morgan Stanley Overweight
2022-01-28 Herabstufung Deutsche Bank Buy → Hold
2021-01-11 Hochstufung Argus Hold → Buy
2021-01-11 Herabstufung Wolfe Research Peer Perform → Underperform
2021-01-08 Herabstufung Wolfe Research Outperform → Peer Perform
2020-07-14 Hochstufung BofA Securities Neutral → Buy
2020-07-13 Hochstufung Wolfe Research Peer Perform → Outperform
2020-06-02 Fortgesetzt Deutsche Bank Buy
2020-05-15 Hochstufung Mizuho Neutral → Buy
2020-04-29 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2020-04-27 Hochstufung Citigroup Neutral → Buy
2020-04-27 Hochstufung Wolfe Research Underperform → Peer Perform
2020-01-08 Eingeleitet Wells Fargo Overweight
2019-07-16 Hochstufung BofA/Merrill Underperform → Neutral
2019-06-21 Hochstufung Deutsche Bank Hold → Buy
2019-04-02 Hochstufung Jefferies Hold → Buy
2019-01-17 Eingeleitet UBS Buy
2019-01-03 Herabstufung BofA/Merrill Neutral → Underperform
2018-12-03 Herabstufung Craig Hallum Buy → Hold
2018-10-30 Herabstufung Argus Buy → Hold
2018-10-25 Herabstufung Canaccord Genuity Buy → Hold
2018-10-19 Fortgesetzt BofA/Merrill Buy
2018-06-07 Hochstufung KeyBanc Capital Mkts Sector Weight → Overweight
2018-05-01 Hochstufung Robert W. Baird Neutral → Outperform
2018-03-23 Eingeleitet Argus Buy
Alle ansehen

Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten

pulisher
Jun 18, 2025

Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? - Nasdaq

Jun 18, 2025
pulisher
Jun 18, 2025

Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care - marketscreener.com

Jun 18, 2025
pulisher
Jun 18, 2025

Labcorp Revolutionizes Healthcare Testing with New 1000+ Biomarker Platform for Holistic Medicine - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

Baird Adjusts Price Target on Labcorp Holdings to $290 From $268, Maintains Outperform Rating - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating - Yahoo Finance

Jun 17, 2025
pulisher
Jun 15, 2025

FTRE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd Announces that Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve

Jun 15, 2025
pulisher
Jun 15, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent

Jun 15, 2025
pulisher
Jun 14, 2025

Kaplan Fox Reminds Fortrea Holdings Inc. (FTRE) Investors of a Securities Class Action Deadline on August 1, 2025 - FinancialContent

Jun 14, 2025
pulisher
Jun 13, 2025

Class Standing Issues Still Murky After Justices Punt LabCorp - Law360

Jun 13, 2025
pulisher
Jun 12, 2025

Labcorp (LH) Gains Exclusive 3D Liver Models from Predictive Onc - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Labcorp director Kerrii Anderson sells shares worth $130,000 By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Labcorp director Kerrii Anderson sells shares worth $130,000 - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Inc. Develops Functional 3D Organoid Models Exclusively for Labcorp - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Kaplan Fox Encourages Investors of Fortrea Holdings Inc. (FTRE) to Contact the Firm Before Lead Plaintiff Deadline on August 1, 2025 - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

Investing in Labcorp Holdings (NYSE:LH) five years ago would have delivered you a 85% gain - simplywall.st

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - Yahoo Finance

Jun 12, 2025
pulisher
Jun 11, 2025

Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH St - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Kirby McInerney LLP Reminds Fortrea Holdings Inc. (FTRE) Investors of Class Action Filing and Encourages Investors to Contact the Firm - FinancialContent

Jun 11, 2025
pulisher
Jun 11, 2025

Kaplan Fox Alerts Investors to a Securities Class Action Against Fortrea Holdings Inc. (FTRE)Deadline is August 1, 2025 - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Labcorp v. Davis Challenge Regarding Uninjured Class Members Dismissed as Improvidently Granted - Wilson Sonsini

Jun 11, 2025
pulisher
Jun 11, 2025

What 8 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga

Jun 11, 2025
pulisher
Jun 11, 2025

Just One Day Away – Register Now for HMG Strategy’s 9th Annual New York CISO & Technology Leadership Summit on June 12 - GlobeNewswire Inc.

Jun 11, 2025
pulisher
Jun 11, 2025

Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Analyst Boosts Price Target for Labcorp (LH) Amid Positive Growt - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Morgan Stanley Raises Price Target on Labcorp Holdings to $283 From $270 - marketscreener.com

Jun 11, 2025
pulisher
Jun 10, 2025

LabCorp stock hits 52-week high at $258.7 amid robust growth By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Justice Kavanaugh Signals One Conservative Vote in Labcorp Toward Imposing a Pre-Certification Standing Requirement Under FRCP 23 - The National Law Review

Jun 10, 2025
pulisher
Jun 10, 2025

LabCorp stock hits 52-week high at $258.7 amid robust growth - Investing.com India

Jun 10, 2025
pulisher
Jun 10, 2025

InStride Redefines Workforce Development Through Strategic Expansion - GlobeNewswire Inc.

Jun 10, 2025
pulisher
Jun 09, 2025

FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve

Jun 09, 2025
pulisher
Jun 06, 2025

SCOTUS Declines to Decide Fate of Classes with Uninjured Members: 8-1 Decision in LabCorp Leaves Unresolved Whether Rule 23 Allows Certification for a Class Containing Members Who Lack Standing - The National Law Review

Jun 06, 2025
pulisher
Jun 06, 2025

SCOTUS DECLINES TO DECIDE FATE OF CLASSES WITH UNINJURED MEMBERS: 8-1 Decision In LabCorp Leaves Unresolved Whether Rule 23 Allows Certification For A Class Containing Members Who Lack Standing - TCPAWorld

Jun 06, 2025
pulisher
Jun 06, 2025

Supreme Court backs off class-action case involving Labcorp, leaving legal questions unresolved - The Business Journals

Jun 06, 2025
pulisher
Jun 06, 2025

Insider Sell: Brian Caveney Sells 2,000 Shares of Labcorp Holdin - GuruFocus

Jun 06, 2025
pulisher
Jun 05, 2025

Should You Continue to Hold Labcorp Stock in Your Portfolio? - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Labcorp EVP Brian Caveney sells $494,000 in common stock By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Labcorp EVP Brian Caveney sells $494,000 in common stock - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

FTRE BREAKING NEWS: Fortrea Holdings Inc. Stock Plummets 25% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NASDAQ:FTRE) - Business Wire

Jun 05, 2025
pulisher
Jun 05, 2025

High Court Drops Class Cert. Clarification Bid - Law360

Jun 05, 2025
pulisher
Jun 05, 2025

Labcorp Holdings Insider Sold Shares Worth $494,000, According to a Recent SEC Filing - marketscreener.com

Jun 05, 2025
pulisher
Jun 03, 2025

Fortrea Faces Investor Suit Over Post-Labcorp Financial Woes - Law360

Jun 03, 2025
pulisher
Jun 03, 2025

FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Fortrea Class Action Lawsuit - The Malaysian Reserve

Jun 03, 2025
pulisher
Jun 03, 2025

FTRE Stockholder Alert: Robbins LLP Informs Investors of the Fortrea Holdings, Inc. Class Action Lawsuit - Morningstar

Jun 03, 2025
pulisher
May 30, 2025

Labcorp Adds New Tests for Solid Tumors, Hematologic Malignancies - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Labcorp Expands Oncology Portfolio to Improve Patient Care and A - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Labcorp (LH) Expands Precision Oncology Portfolio with New Offerings | LH Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research - Financial Times

May 30, 2025
pulisher
May 30, 2025

Labcorp Revolutionizes Cancer Care: New Test Portfolio Promises Faster Treatment Decisions - Stock Titan

May 30, 2025

Finanzdaten der Labcorp Holdings Inc-Aktie (LH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$168.94
price up icon 0.58%
diagnostics_research WAT
$349.04
price down icon 0.96%
diagnostics_research DGX
$179.63
price up icon 1.01%
diagnostics_research MTD
$1,174.72
price down icon 0.83%
diagnostics_research IQV
$157.59
price up icon 0.08%
Kapitalisierung:     |  Volumen (24h):